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Abstract:  
Objective: To investigate the associations between using alternatives to the car which are more active for 
commuting and non-commuting purposes and morbidity and mortality 
 
Methods: We conducted a prospective study using 358799 participants aged 37-73 from UK Biobank. 
Commute and non-commute travel were assessed at baseline in 2006-2010. We classified participants 
according to whether they relied exclusively on the car, or used alternative modes of transport that were 
more active at least some of the time. Main outcome measures were incident CVD and cancer, and CVD, 
cancer and all-cause mortality. We excluded events in the first two years and conducted analyses 
separately for those who regularly commuted and those who did not. 
 
Results: In maximally-adjusted models, regular commuters with more active patterns of travel on the 
commute had a lower risk of incident (HR 0.89, 95% CI 0.79 to 1.00) and fatal CVD (HR 0.70, 95% CI 
0.51 to 0.95). Those regular commuters who also had more active patterns of non-commute travel had an 
even lower risk of fatal CVD (HR 0.57, 95% CI 0.39 to 0.85). Among those who were not regular 
commuters, more active patterns of travel were associated with a lower risk of all-cause mortality (HR 
0.92, 95% CI 0.86 to 0.99). 
  
Conclusions: More active patterns of travel are associated with a reduced risk of incident and fatal CVD 
and all-cause mortality in adults. This is an important message for clinicians advising people about how to 
be physically active and reduce their risk of disease. 
 
 
What is already known on this subject 
• Physical inactivity is an important risk factor for cardiovascular disease.  
• Current clinical practice guidelines recommend physical activity, although the benefits of active 
travel on mortality and morbidity are still unclear. 
What this study adds 
• We examined the association of active travel with mortality and morbidity in a cohort study. 
• More active travel patterns were associated with significant reductions in cardiovascular disease 
(CVD).  
• Those who used more active modes of travel for commuting and non-commuting purposes also 
had an even lower risk of fatal CVD.  
• Among those who were not regular commuters, more active travel was associated with a lower 
risk of all-cause mortality. 
How might this impact on clinical practice? 
• This is important for clinicians advising people about how to be physically active and reduce their 
risk of disease. 
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INTRODUCTION 
 
Physical activity, including less vigorous forms of physical activity such as walking and cycling, reduce 
the risk of cardiovascular disease (CVD).1 Despite the knowledge of its benefits, levels of activity are still 
low in many countries.2 With increasingly sedentary occupations and busy lives, many people have little 
time for leisure-time physical activity. Activity as part of a journey, such as the commute or for transport 
in general, offers a comparatively easy way to integrate exercise into daily life.3  
 
Prospective observational studies have shown associations between walking or cycling to work and 
health, principally through a reduced risk of cardio-metabolic disease.4-6 While there is a good scientific 
rationale for focusing on walking or cycling to work due to its regular nature, for many comparatively 
car-dependent populations walking or cycling the entire journey is impractical because of the distances 
involved. For example, in the UK only 17% of adults live within easy walking distance (2km) of work 
and only 35% live within easy cycling distance (5km).7 However, it is possible to incorporate more 
physical activity into journeys without completely replacing motor vehicle use, for example by using 
public transport, or walking or cycling parts of longer journeys made by car. These travel patterns involve 
more physical activity than exclusive car use and can add up, over the course of a typical working week, 
to a substantial amount of activity.8,9 These travel patterns are prevalent in some, particularly urban and 
peri-urban populations,10 and are likely to be more achievable for many people, but have been rarely 
studied.9 In addition, with increases in home and remote working combined with an aging population,11 
an increasing proportion of adults are less likely to make regular commutes. Much research is focused on 
the benefits of active commuting, however the potential health gains associated with non-commuting 
travel are less well known. 
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We aimed to extend previous research by using data from a large epidemiological cohort to investigate 
prospective associations between more active patterns of travel relative to exclusive car use and 
cardiovascular disease (CVD), cancer and all-cause mortality in the general adult population. 
 
METHODS 
 
Study population and sample 
We used data from UK Biobank, a national population-based study of 502,639 men and women aged 37 
to 73 years.12,13 Potential participants were selected through population-based registers of patients 
registered with the National Health Service (NHS) from across England, Scotland, and Wales. Those 
living within 35km of any of 22 assessment centres were invited. At baseline (March 2006-July 2010) 
participants reported information on socio-demographic characteristics, physical activity and health 
conditions. All participants provided informed consent. 
 
As there were some differences in demographic and health characteristics between those who commuted 
regularly and those who did not, we stratified our sample. We defined regular commuters as those 
participants who reported being employed, travelled to work at least three times/week and reported a 
home-to-work distance of greater than zero. Those not regularly commuting therefore comprised those 
who were not employed (e.g. retired or unemployed), along with those who were employed but reported 
either travelling to work less than three times/week or a home-to-work distance of zero miles. We chose 
this definition as those working part time or commuting only part of the week constituted a small 
proportion of the total and were more similar to those who were not regularly commuting. Participants 
with missing information on employment status or commute frequency or distance were excluded (Figure 
1). 
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Exposures 
 
Commute travel 
Participants in employment were asked ‘What types of transport do you use to get to and from work?’ Six 
response options were given: car/motor vehicle, public transport, cycle, walk, ‘none of the above’ and 
‘prefer not to answer’. Participants could select more than one response. 
 
Using these responses, we divided participants into two behavioural patterns or ‘phenotypes’: (a) those 
who reported exclusive use of the car, and (b) those who reported any other travel pattern (‘more active 
patterns of travel’), i.e. including some walking, cycling or public transport, either alone or in 
combination with the car. Participants who reported ‘none of the above’ or ‘prefer not to answer’ were 
excluded.  
 
Non-commute travel  
All participants were asked ‘In the last 4 weeks, which forms of transport have you used most often to get 
about?’ with occupational travel specifically excluded and the same response options were provided as 
for the question on commuting. We classified these responses in the same way. 
 
Commute and non-commute travel 
In addition, we classified regular commuters into one of four categories according to whether they 
reported exclusive car use for commuting, non-commuting travel, both, or neither. 
 
Outcomes  
We studied five main outcomes: incident and fatal cardiovascular disease (International Classification of 
Disease 10th revision, codes I20-25 for ischaemic heart disease and I60-69 for cerebrovascular disease), 
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incident and fatal cancer (excluding all skin cancer, (melanoma and other malignant neoplasms) C43-44), 
and all-cause mortality. In addition we studied four other outcomes: incident and fatal colon cancer (C18) 
and incident and fatal breast cancer (C19), with which a lack of physical activity has been shown to be 
specifically associated.14,15 To minimise the potential effects of reverse causation we excluded all 
participants with new events in the two-year period after baseline assessment. Outcomes were identified 
by linkage to hospital records, the national cancer registry, and death certificates. Censoring dates for 
these datasets differed and differed in different regions but all were complete up to 3 November 2015. For 
example, hospital admission data for England were available up to 31 March 2015 but for Wales it was 
later (29 February 2016). 
 
Covariates 
Data from the baseline questionnaire were used to assess age, sex, ethnicity, highest educational 
qualification, occupation, household income, access to a car, dietary intake (through measures of 
consumption of fruit and vegetables), alcohol consumption, smoking status, occupational and recreational 
physical activity, shift working, sleep and screen time, longstanding illness/disability, medical conditions 
(high blood pressure, diabetes) and medication usage. Height and weight were measured at the 
assessment centre and used to compute body mass index (BMI). Area-level indices (Townsend score of 
deprivation and urban/rural status) were derived from home postcodes.  
 
Statistical analyses 
We used Cox regression to estimate the associations between more active patterns of travel and the 
hazard of each outcome. We made progressive adjustments to account for potential confounders (model 
1: demographic and geographical characteristics; model 2: individual socio-economic characteristics; 
model 3: other behaviours; model 4: other health conditions) restricting all models for a given outcome to 
participants with complete data for all covariates in model 4. Full details are provided in Table A1, 
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Additional file 1. For all outcomes, individuals with prevalent conditions were excluded (e.g for CVD 
mortality, those with prevalent CVD were excluded). The proportional hazards assumption was assessed 
using log-log survival plots and graphical checks suggested the assumptions were reasonable.  
 
For each of the main outcomes in regular commuters, we tested interactions between the exposure and car 
access (none, 1, 2 or more) and home-to-work distance (<3 miles v >3 miles). We chose these categories 
based on the prevalence of exclusive car use and distances reported in our sample. These characteristics 
may limit available travel options, be socially and spatially patterned, and thereby moderate the 
associations observed. 
 
Sensitivity analyses 
Given the limited number of events observed, we undertook a sensitivity analysis excluding only 
participants with events in the first year (rather than two years). 
 
RESULTS 
Sample characteristics and travel patterns 
In total, data from 358 799 participants were included in the analysis. Those included were more likely to 
report at least degree-level education, higher occupational status and higher household incomes, and to 
engage in higher levels of physical activity, than those who were excluded (Table A2, Additional File 2). 
Of those included in analysis, 187 281 were regular commuters (mean age at baseline 52.1 + 6.8 years) 
and 171 498 were not (mean age 60.7 +6.9 years; Table 1). Regular commuters tended to be younger and 
healthier and to report a higher household income than those who did not regularly commute. Around 
two-thirds of commuters relied exclusively on the car to travel to work, with more active travel patterns 
being more frequently reported for non-commuting travel (Table 2). While 81.7% of regular commuters 
and 77.3% of other participants reported using the car at least some of the time for non-commuting travel, 
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22.4% and 36.5% respectively reported some public transport use and 44.9% and 52.5% respectively 
reported some walking. Cycling was less prevalent, being mentioned by 8.5% and 7.0% of regular 
commuters for commuting and non-commuting travel respectively, and by 4.8% of other participants. 
 
Associations with main outcomes  
Figure 2 shows the maximally-adjusted associations (model 4) between more active patterns of travel and 
the outcomes and Tables A3-A5 in Additional File 2 show the breakdown of progressive adjustment 
(models 1-4). 
 
Regular commuters  
Among regular commuters, more active patterns of travel for commuting were associated with estimated 
reductions of 11% in incident cases and 30% in fatal cases of CVD in models adjusted for demographic 
and socio-economic characteristics, physical activity and dietary behaviours, and other health conditions 
(HR 0.89, 95% CI 0.79 to 1.00 and HR 0.70, 95% CI 0.51 to 0.95, respectively: Figure 2 and Table A3). 
More active patterns of travel for commuting were not significantly associated with incident or fatal 
cancer or all-cause mortality, and were not significantly associated with any of the outcomes for non-
commuting travel (Figure 2 and Table A3). However, the dual exposure of more active patterns of 
commuting and non-commuting travel was associated with an estimated 43% reduction in fatal CVD 
events compared with exclusive car use for both types of travel in maximally-adjusted models (HR 0.57, 
95% CI 0.39 to 0.85; Figure 2 and Table A4). This dual exposure was also associated with a reduction in 
incident CVD in model 3, but the association was no longer significant in the maximally-adjusted model 
which included other health conditions (model 4).  
 
Those not making regular commutes  
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Among those not making regular commutes, more active patterns of travel were associated with an 
estimated 8% reduction in all-cause mortality in maximally-adjusted models (HR: 0.92; 95%CI: 0.86 to 
0.99, Table A5, Additional File 2). Associations for incident CVD and incident and fatal cancer were no 
longer significant in maximally-adjusted models. 
 
Associations with other outcomes 
There were no significant associations with breast or colon cancer incidence or mortality in any models 
(Table A6, Additional File 2). 
 
Sensitivity analyses and interactions  
After relaxing the exclusion criteria such that only participants with events in the first year were excluded, 
the associations observed were of similar magnitude to those observed in the main analyses, with 
confidence intervals tending to be slightly narrower. Two associations became significant in regular 
commuters, for whom more active patterns of non-commuting travel were now associated with a lower 
risk of CVD and all-cause mortality (HR 0.76, 95% CI 0.59 to 0.98 and HR 0.91, 95% CI 0.83 to 1.00 
respectively). 
 
We found no evidence that any of the associations between more active patterns of travel and the five 
main outcomes were moderated by distance to work or car access (all p> 0.01).  
 
DISCUSSION 
 
Principal findings 
Although not all associations were significant, the general pattern of our results indicates that, irrespective 
of other physical activity, more active patterns of travel, compared to exclusive car use, were associated 
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with reductions in risk of incident and fatal CVD and all-cause mortality. Of note, in regular commuters, 
more active patterns of travel were associated with a reduced risk of both incident (11%) and fatal (30%) 
CVD; the reduction in CVD mortality was increased to 43% among those who used more active patterns 
for non-commuting travel. The latter exposure was also associated with a significant, albeit smaller (8%), 
reduction in all-cause mortality among those who were not regular commuters.  
 
Strengths and limitations 
Strengths of this analysis include use of a very large multi-centre general population dataset, a focus on 
feasible travel choices for commuting and non-commuting travel, and the linkage to objectively 
ascertained morbidity and mortality outcomes using national datasets. Our analysis extends previous 
research6 in important ways. These include more stringent exclusion of prevalent conditions, and incident 
cases occurring in the first two years; adjustment for a more comprehensive set of potential individual-
level confounders and other covariates, ranging from markers of socio-economic position to behavioural 
(sleep, diet and other physical activity) characteristics and mostly self-reported health conditions; and 
consideration of non-commuting travel as an important exposure alongside the more frequently-
researched activity of commuting. In general, the progressive adjustment indicated that the magnitude of 
the associations were very similar (even if some results became non-significant). In combination, these 
approaches are likely to have reduced but not eliminated the risks of reverse causation, residual 
confounding and a healthy worker effect, any of which might lead to an overestimation of the true effects. 
UK Biobank participants are less ethnically diverse and healthier than the general UK population,14 and a 
substantial number gave insufficient information on key variables for them to be included in analysis. 
Participants who were excluded from analysis also tended to report lower levels of physical activity, 
lower occupational classification and lower educational attainment than those who were included. While 
this admittedly limits the generalisability of some of our descriptive statistics to the national population, 
there is no particular reason to believe that our results are not generalisable in principle. Our analyses, 
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assume that travel patterns remain relatively stable over follow-up. We did not have information about 
changes in activity from the entire cohort, but repeated measures in less than 2% of our sample 4 years 
after baseline indicated that patterns of commuting remained very stable for the majority.16 
 
Comparison with other research 
Our results are consistent with previous research suggesting that replacing exclusive car use with more 
active travel patterns may be beneficial for health.17 Of all the outcomes investigated, our results for 
incident and fatal CVD in regular commuters appear the strongest. The findings of a previous systematic 
review focused on active commuting and cardiovascular disease,5 as well as those of more recent studies, 
are somewhat inconsistent: some report positive (protective) associations for incident or fatal CVD,5,18 
while others report null associations19-21 or mixed associations.22,23 However, given that our sample is 
substantially larger than that used in all but one of these previous studies5, we suggest that our results shift 
the overall balance of evidence to a position that more clearly supports the potential contribution of active 
travel to the primary prevention of cardiovascular disease in commuters. This is supported by other 
epidemiological evidence linking cardiovascular outcomes with physical activity in general,24 and linking 
active commuting and regular physical activity with plausible biological mechanisms such as blood 
pressure reduction and anti-inflammatory effects.6 
 
We also found that more active patterns of travel were associated with a reduced risk of all-cause 
mortality among those not regularly commuting. This result is in line with a meta-analysis25 which found 
that walking and cycling for either commuting or recreation were associated with reduced all-cause 
mortality. While the associations for more active travel with mortality have not previously been 
investigated in non-commuters, a systematic review examined the association between walking and 
cycling and mortality.17 In that review, of the five studies examining associations between active travel 
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and all-cause mortality, only one found significant association which was observed for cycle commuting 
(walking on the commute was not examined in that study).  
 
In terms of cancer outcomes, the associations we observed, although protective, were small and non-
significant. Relatively few studies have described the associations between active travel and risk of 
incident or fatal cancers.26 Our non-significant findings may reflect the small numbers of cases of breast 
and colon cancer (the cancers with which physical activity in general appears to be most strongly 
associated) and the short follow-up period relative to the aetiological time period of cancer development. 
 
Implications for policy and practice 
Taken together and in the light of existing evidence, our findings provide further support for a hypothesis 
that more active patterns of travel for both commuting and non-commuting purposes, may be associated 
with significant reductions in CVD and all-cause mortality. This is an important message for clinicians 
advising people about how to be physically active and reduce their risk of disease. We also found no 
evidence that these associations were moderated by car access which could be explained by the 
heterogenous nature of the group who did not rely on car use, but it may also suggest that the benefits are 
available to all irrespective of car access or distance to work.  
 
Demographic and technological trends in countries such as the UK are thought likely to result in a 
reduced requirement for commuting over time and a dispersal of older people towards more rural areas,11 
both of which will increase the importance of non-commuting travel. Interventions that encourage people 
to reduce their car use in favour of making more use of public transport, walking, cycling, or 
combinations thereof may be more widely applicable than efforts to promote walking or cycling in 
particular – especially among people whose circumstances preclude, for example, cycling all the way to 
work, or giving up the car completely in a rural area. Our own previous research has highlighted the 
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potential health gains associated with integrating walking or cycling stages into longer journeys by car or 
public transport,9 a target for public health intervention also supported by recommendations from NICE,27 
the UN, and WHO28. 
 
Implications for future research 
Longer-term or more rigorous longitudinal analysis could investigate in more detail the extent to which 
changes in travel behaviour result in individual health benefits. Cohorts such as UK Biobank provide the 
opportunity to follow-up large numbers of people at regular intervals (not just at baseline) over a longer 
period of time, and the accrual of more cases of disease over time will increase the power to detect 
associations that may not have become apparent to date. Collecting more detailed information about the 
frequency, duration and modal composition of trips, whether in this cohort or other future studies, would 
enable more definitive investigation of these associations and the extent to which they are modified by car 
access, distance or other factors.  
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Figure 1:  Sample of UK Biobank participants for analysis 
Figure 2: Maximally-adjusted hazard ratios for more active patterns of travel (compared to exclusive car 
use) and all-cause mortality, incident and fatal cardiovascular disease (CVD) and cancer for regular 
commuters and those not making regular commutes 
 
Figure legend: The hazard ratio for commuting & non-commuting travel are for commuters who use more active patterns of 
travel at least some of the time relative to commuters who rely exclusively on the car for both commuting and non-commuting 
travel. 
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Table 1: Characteristics of the sample at baseline  
 
 Regular commuters  
(n= 187281) 
Not regularly commuting  
(n= 171498) 
 Mean SD Mean SD 
Follow-up time (years) 7.0 0.9 6.9 1.1 
Age (yrs) 52.1 6.8 60.7 6.9 
BMI (kg/m2) 27.2 4.7 27.5 4.8 
Weekly time spent walking for leisure 77.3 124.3 123.2 180.2 
Weekly time spent in strenuous sports 20.1 71.7 13.3 65.9 
Weekly time spent in other exercises 61.8 110.5 66.8 129.8 
Weekly time spent in DIY activities 92.1 209.4 134.4 276.6 
     
 % N % N 
Sex     
Women 50.9 95294 53.6 91890 
Men 49.1 91987 46.4 79608 
Smoking status     
Never 58.0 108580 50.9 87357 
Previous 31.4 58726 39.3 67448 
Current 10.7 19975 9.7 16693 
Ethnicity       
White 94.9 177654 96.9 166167 
Non-white 5.1 9627 3.1 5331 
Education       
University degree 39.2 73396 30.9 52967 
A-Levels 35.4 66322 31.2 53518 
GCSE or equivalent 16.7 31310 16.6 28453 
None 8.7 16253 21.3 36560 
Residential status     
Urban 86.9 162711 84.1 144158 
Town and fringe 6.6 12428 7.7 13155 
Rural 6.5 12142 8.3 14185 
Occupation     
Managerial/professional 60.0 112389 22.1 37888 
Administrative/skilled trades 22.5 42227 7.3 12495 
Professional/customer services 8.6 16175 3.1 5349 
Operatives/labourers/other 8.8 16490 2.6 4471 
Not applicable (e.g. retired) 0.0 0 64.9 111295 
Income     
<£31000 30.2 56640 65.2 111739 
£31000-<£52000 32.3 60578 19.9 34169 
≥£52000 37.4 70063 14.9 25590 
Number of cars owned     
0 5.8 10769 9.7 16639 
1 37.0 69216 47.0 80591 
2 or more 57.3 107296 43.3 74268 
Shift work     
None 83.2 155825 97.4 167036 
Day only 8.2 15373 1.2 2101 
Includes nights 8.6 16083 1.4 2361 
Physical activity at work     
Not applicable 0.0 0 80.7 138378 
Manual 12.4 23282 1.8 3052 
Standing/walking/some manual 30.1 56311 5.5 9440 
Light sedentary 22.9 42819 4.1 7072 
Sedentary 34.6 64869 7.9 13556 
Longstanding limiting illness or disability     
No 75.6 141669 60.9 104436 
Yes 24.4 45612 39.1 67062 
Any medication used     
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No 82.2 153968 63.5 108827 
Yes 17.8 33313 36.5 62671 
 
 
 
 
Table 2: Exclusive use of the car in non-commuters and commuters 
 
Travel patterns 
 
 
 Sample 
% (N) 
Mean (SD) 
follow-up  
time 
Regular commuters 
 
 
Commuting   
Relying exclusively on the car 63.8 (119394) 7.0 (0.9) 
More active patterns of travel 36.2 (67668) 7.0 (0.9) 
Non-commuting    
Relying exclusively on the car 45.1 (84347) 7.0 (0.9) 
More active patterns of travel 54.9 (102473) 7.0 (0.9) 
Commuting and non-commuting travel   
Exclusive use of a car 37.5 (69824) 7.0 (0.9) 
Exclusive use of a car for commuting, more active patterns of travel 
for non-commuting 
26.3 (49236) 7.0 (0.9) 
More active patterns of travel for commuting, exclusive use of a car 
for non-commuting 
7.7 (14450) 7.0 (0.9) 
More active patterns of travel for commuting and non-commuting 28.5 (53120) 7.0 (0.9) 
Not regular commuters   
Non-commuting    
Relying exclusively on the car 34.5 (59143) 6.9 (1.1) 
More active patterns of travel 65.5 (112073) 6.9 (1.0) 
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Additional file 1: Additional methods 
 
Table A1: Summary of co-variates adjusted for and exclusions applied in hazard models for five main outcomes  
 
 All-cause mortality Incident CVD CVD mortality Incident cancer* Cancer mortality* 
Exclusions Deaths within first 2 years of follow-up are 
excluded. 
 
Individuals with prevalent heart disease (including 
angina)/stroke (based on self-report or HES data, 
i.e. variable 43 or 44) or prevalent cancer at 
baseline (based on either self-report or cancer 
registry) are excluded. 
MI/stroke within first 2 years of 
follow-up are excluded.   
 
Individuals with prevalent heart 
disease (including angina)/stroke at 
baseline are excluded (based on self-
report or HES data, i.e. variable 43 or 
44) 
CVD deaths (defined as I200/I259 and 
I600/I698) within first 2 years of follow-up 
are excluded.  
Individuals with prevalent heart disease 
(including angina)/stroke at baseline (based 
on self-report or HES data, i.e. variable 43 
or 44) are excluded.  
Cancers within first 2 years 
of follow-up are excluded.  
Individuals with prevalent 
cancer are excluded (based 
on self-report or cancer 
registry). 
Cancer deaths within first 2 years 
of follow-up are excluded.  
Individuals with prevalent cancer 
are excluded (based on information 
from cancer registry or self-report). 
Co-variates      
Model 1 Age, sex, ethnicity, urban/rural, area-level 
deprivation 
As for all-cause mortality As for all-cause mortality As for all-cause mortality As for all-cause mortality 
Model 2 Model 1 + education, occupation, income + car 
access 
As for all-cause mortality As for all-cause mortality As for all-cause mortality As for all-cause mortality 
Model 3 Model 2 + fresh fruit, raw vegetables, cooked 
vegetables, smoking, PA at work, strenuous sport 
duration, other exercise duration, leisure walking 
duration, DIY duration, shift work, alcohol, 
longstanding limiting illness /disability, sleep time 
(3 categories: <7h, 7-8h, >8h) and screen time (TV 
and computer viewing combined) 
As for all-cause mortality As for all-cause mortality As for all-cause mortality As for all-cause mortality 
Model 4 Model 3 + high BP (self-report), medication for 
high blood pressure, BMI, medication for high 
cholesterol, medication for diabetes, diabetes 
diagnosis (self-report)  
As for all-cause mortality As for all-cause mortality Model 3 + BMI.  Model 3 + BMI 
* excluding all skin cancers (melanoma and other malignant neoplasms of the skin) 
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Additional file 2: Additional results 
 
Table A2: Baseline characteristics in those included/excluded from the sample 
 
  
Excluded from the main analysis 
(N=143854) 
Included in the main analysis 
(N=358779) 
  % missing Mean SD % missing Mean SD 
Follow-up time (years) 0.0 7.0 1.1 0.0 7.0 1.0 
Age (yrs) 0.0 57.3 8.1 0.0 56.2 8.1 
BMI (kg/m2) 2.2 27.6 5.0 0.0 27.4 4.7 
Strenuous sports duration (mins/wk) 5.0 12.0 62.1 0.0 16.8 69.1 
Other exercise duration (mins/wk) 5.0 56.0 117.9 0.0 64.2 120.1 
DIY duration (mins/wk) 5.0 106.4 257.2 0.0 112.3 244.8 
Leisure walking duration (mins/wk) 5.0 100.3 168.2 0.0 99.3 155.3 
  % N % N 
Sex 0.0   0.0   
Women 60.0 86278   52.2 187184 
Men 40.0 57576   47.8 171595 
Smoking status 2.1   0.0   
Never 54.0 77660   54.6 195937 
Previous 32.6 46921   35.2 126174 
Current 11.3 16321   10.2 36668 
Ethnicity 1.9   0.0   
White 89.7 129065   95.8 343821 
Non-white 8.4 12071   4.2 14958 
Education 3.2   0.0   
University degree 24.2 34843   35.2 126363 
A-Levels 29.8 42843   33.4 119840 
GCSE or equivalent 16.4 23547   16.7 59763 
None 26.4 37974   14.7 52813 
Residential status 3.5   0.0   
Urban 84.8 122021   85.5 306869 
Town and fringe 5.8 8291   7.1 25583 
Rural 5.9 8467   7.3 26327 
Employment status 4.0   0.0   
Employed - including voluntary/student work 56.9 81834   61.4 220415 
Unable to work due to sickness 4.8 6855   3.4 12082 
Not employed/retired 34.3 49405   35.2 126282 
Occupation 12.7   0.0   
Managerial/professional 19.3 27782   41.9 150277 
Administrative/skilled trades 12.2 17608   15.3 54722 
Professional/customer services 5.9 8533   6.0 21524 
Operatives/labourers 6.4 9179   5.8 20958 
Not applicable (e.g. retired) 43.4 62436   31.0 111298 
Income 53.7   0.0   
<£31000 25.8 37045   46.9 168379 
£31000-<£52000 11.2 16045   26.4 94747 
≥£52000 9.4 13565   26.7 95653 
Number of cars owned 3.2   0.0   
0 11.7 16816   7.6 27408 
1 40.9 58821   41.8 149807 
2 or more 44.2 63559   50.6 181564 
Shift work 0.5   0.0   
None 90.0 129486   90.0 322861 
Day only 4.7 6762   4.9 17474 
Includes nights 4.8 6928   5.1 18444 
Physical activity in workplace 14.6   0.0   
Not applicable 39.1 56302   38.6 138378 
Manual 8.6 12368   7.3 26334 
Standing/walking/some manual 16.3 23397   18.3 65751 
Light sedentary 9.1 13158   13.9 49891 
Sedentary 12.3 17636   21.9 78425 
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Longstanding limiting illness or disability 8.7   0.0   
No 58.5 84144   68.6 246105 
Yes 32.9 47266   31.4 112674 
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Table A3: Prospective associations between travel mode and all-cause, cardiovascular and cancer mortality and incident CVD and cancer for those regularly commuting 
  
 All-cause mortality Incident CVD CVD mortality Incident cancer† Cancer mortality† 
Commuting Events Person years Events Person years Events Person years Events Person years Events Person years 
Relying exclusively on 
the car 1109 767351 1118 809613 175 814706 2704 778301 737 792122 
More active patterns of 
travel 588 432773 477 456541 65 458599 1442 437698 366 444612 
 
N=170511 HR (95%CI) N=180942 HR (95%CI) N=181388 HR (95%CI) N=174381 HR (95%CI) N=175877 HR (95%CI) 
Model 1  0.96 (0.86 to 1.06)  0.77 (0.69 to 0.86)  0.66 (0.49 to 0.89)  0.99 (0.92 to 1.05)  0.90 (0.79 to 1.03) 
Model 2  0.95 (0.85 to 1.06)  0.84 (0.74 to 0.94)  0.67 (0.49 to 0.91)  0.99 (0.92 to 1.06)  0.93 (0.81 to 1.06) 
Model 3  0.98 (0.88 to 1.10)  0.87 (0.77 to 0.98)  0.68 (0.50 to 0.93)  1.00 (0.93 to 1.07)  0.96 (0.83 to 1.10) 
Model 4  1.00 (0.89 to 1.12)  0.89 (0.79 to 1.00)  0.70 (0.51 to 0.95) 
 
 1.00 (0.94 to 1.08) 
 
 
 
0.97 (0.84 to 1.11) 
Other travel Events Person years Events Person years Events Person years Events Person years Events Person years 
Relying exclusively on 
the car 
818 542960 781 572094 124 575687 1932 550434 539 560120 
More active patterns of 
travel 
881 655676 813 692434 114 696000 2212 664003 566 675010 
 
N=170306 HR (95%CI) N=180716 HR (95%CI) N=181163   HR (95%CI) N=174165 HR (95%CI) N=175656 HR (95%CI) 
Model 1  0.88 (0.80 to 0.97)   0.86 (0.78 to 0.95)   0.75 (0.58 to 0.97)  0.96 (0.90 to 1.02)  0.86 (0.76 to 0.97) 
Model 2  0.86 (0.78 to 0.95)   0.90 (0.81 to 1.00)   0.75 (0.58 to 0.98)  0.96 (0.90 to 1.02)   0.87 (0.77 to 0.98) 
Model 3  0.91 (0.83 to 1.01)   0.95 (0.85 to 1.05)   0.77 (0.59 to 1.01)  0.98 (0.91 to 1.04)   0.91 (0.81 to 1.03) 
Model 4  0.92 (0.83 to 1.02)   0.96 (0.87 to 1.07)   0.78 (0.60 to 1.02)  0.98 (0.92 to 1.05)   0.92 (0.81 to 1.04) 
For non-commuting travel, the reference group is those who use the car for non-commuting travel. For commuting the reference group is those who use the car for commuting. HR: Hazard 
Ratios; CI: Confidence Interval. 
Model 1: age (underlying timescale), sex, ethnicity, urban/rural, area-level deprivation. 
Model 2: Model 1 plus education, occupation, household income, cars owned. 
Model 3: Model 2 plus fresh fruit, raw vegetables, cooked vegetables, smoking, PA at work, strenuous sport duration, other exercise duration, leisure walking duration, DIY duration, shift 
work, alcohol consumption, longstanding limiting illness/disability, sleep time, screen time. 
Model 4: Model 3 plus hypertension, medication for high blood pressure, BMI, medication for high cholesterol, medication for diabetes, diabetes diagnosis. 
† For cancer outcomes Model 4 adjusted for all variables in Model 3 plus BMI only  
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Table A4: Prospective associations between the commuting and non-commuting travel and all-cause, cardiovascular and cancer mortality and incident CVD and cancer for 
those regularly commuting 
 
HR (95% CI) 
 
All-cause mortality 
N=170127 
  Incident CVD    
N=180533             
CVD mortality 
N=180979 
Incident cancer  
N=173982 
Cancer mortality  
N=175472 
Model 1      
Exclusive use of a car for commuting, more active patterns of travel for non-commuting 
travel 
0.87 (0.77 to 0.98) 0.91 (0.81 to 1.03) 0.97 (0.72 to 1.31) 0.96 (0.89 to 1.04) 0.87 (0.75 to 1.01) 
More active patterns of travel for commuting, exclusive use of a car for non-commuting 0.99 (0.82 to 1.19) 0.76 (0.62 to 0.94) 1.08 (0.67 to 1.72) 1.01 (0.90 to 1.14) 0.95 (0.75 to 1.20) 
More active patterns of travel for commuting and non-commuting 0.88 (0.78 to 1.00) 0.74 (0.65 to 0.84) 0.55 (0.39 to 0.80) 0.96 (0.88 to 1.04) 0.83 (0.71 to 0.97) 
Model 2      
Exclusive use of a car for commuting, more active patterns of travel for non-commuting 
travel 
0.86 (0.76 to 0.97) 0.92 (0.81 to 1.04) 0.96 (0.70 to 1.30) 0.96 (0.89 to 1.04) 0.87 (0.75 to 1.01) 
More active patterns of travel for commuting, exclusive use of a car for non-commuting 1.01 (0.83 to 1.22) 0.81 (0.65 to 1.00) 1.10 (0.69 to 1.77) 1.02 (0.90 to 1.15) 0.97 (0.77 to 1.24) 
More active patterns of travel for commuting and non-commuting 0.86 (0.76 to 0.98) 0.81 (0.70 to 0.93) 0.54 (0.37 to 0.80) 0.96 (0.88 to 1.04) 0.84 (0.72 to 0.99) 
Model 3      
Exclusive use of a car for commuting, more active patterns of travel for non-commuting 
travel 
0.91 (0.80 to 1.03) 0.97 (0.86 to 1.09) 0.99 (0.73 to 1.35) 0.98 (0.91 to 1.06) 0.92 (0.79 to 1.06) 
More active patterns of travel for commuting, exclusive use of a car for non-commuting 1.04 (0.86 to 1.26) 0.85 (0.68 to 1.05) 1.15 (0.71 to 1.85) 1.02 (0.91 to 1.16) 1.01 (0.79 to 1.28) 
More active patterns of travel for commuting and non-commuting 0.92 (0.80 to 1.05) 0.86 (0.75 to 0.99) 0.56 (0.38 to 0.83) 0.98 (0.90 to 1.06) 0.90 (0.76 to 1.06) 
Model 4      
Exclusive use of a car for commuting, more active patterns of travel for non-commuting 
travel 
0.92 (0.81 to 1.04) 0.98 (0.87 to 1.11) 1.00 (0.73 to 1.36) 0.98 (0.91 to 1.06) 0.92 (0.79 to 1.07) 
More active patterns of travel for commuting, exclusive use of a car for non-commuting 1.05 (0.87 to 1.28) 0.86 (0.70 to 1.07) 1.16 (0.72 to 1.87) 1.03 (0.91 to 1.16) 1.01 (0.80 to 1.29) 
More active patterns of travel for commuting and non-commuting 0.94 (0.82 to 1.07) 0.89 (0.77 to 1.02) 0.57 (0.39 to 0.85) 0.99 (0.91 to 1.07) 0.91 (0.77 to 1.07) 
HR: Hazard Ratios; CI: Confidence Interval. In models 1-4, the reference group is those who use the car for both commuting and non-commuting travel. 
Model 1: age (underlying timescale), sex, ethnicity, urban/rural, area-level deprivation. 
Model 2: Model 1 plus education, occupation, household income, cars owned. 
Model 3: Model 2 plus fresh fruit, raw vegetables, cooked vegetables, smoking, PA at work, strenuous sport duration, other exercise duration, leisure walking duration, DIY duration, shift 
work, alcohol consumption, longstanding limiting illness/disability, sleep time, screen time. 
Model 4: Model 3 plus hypertension, medication for high blood pressure, BMI, medication for high cholesterol, medication for diabetes, diabetes diagnosis. 
† For cancer outcomes Model 3 adjusted for all variables in Model 3 plus BMI only   
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Table A5: Prospective associations between travel mode and all-cause, cardiovascular and cancer mortality and incident CVD and cancer for those not regularly 
commuting 
 
 All-cause mortality 
 
Incident CVD  
 
CVD mortality  
 
Incident cancer†  
 
Cancer mortality†  
 
 Events Person years Events Person years Events Person years Events Person years Events Person years 
Relying exclusively on 
the car 
1211 330672 940 366984 174 370968 2215 354331 798 365325 
More active patterns of 
travel 
2245 632070 1681 699439 351 706259 4001 670139 1446 690701 
 HR (95%CI)  
 N=138352 N=155074 N=138352 N=149726 N=152222 
Model 1 
Model 2 
Model 3 
Model 4 
0.88 (0.82 to 0.95) 
0.84 (0.78 to 0.90) 
0.92 (0.85 to 0.99) 
0.92 (0.86 to 0.99) 
0.89 (0.82 to 0.96) 
0.87 (0.80 to 0.95) 
0.93 (0.85 to 1.01) 
0.94 (0.87 to 1.03) 
0.97 (0.80 to 1.16) 
0.88 (0.73 to 1.06) 
0.96 (0.79 to 1.17) 
0.98 (0.81 to 1.20) 
0.91 (0.87 to 0.96) 
0.93 (0.88 to 0.98) 
0.95 (0.90 to 1.00) 
0.95 (0.90 to 1.01) 
0.88 (0.81 to 0.97) 
0.88 (0.81 to 0.97) 
0.94 (0.86 to 1.03) 
0.95 (0.86 to 1.04) 
The reference group is those who use the car for travel. HR: Hazard Ratios; CI: Confidence Interval. 
Model 1: age (underlying timescale), sex, ethnicity, urban/rural, area-level deprivation. 
Model 2: Model 1 plus education, occupation, household income, cars owned. 
Model 3: Model 2 plus fresh fruit, raw vegetables, cooked vegetables, smoking, PA at work, strenuous sport duration, other exercise duration, leisure walking duration, DIY duration, shift 
work, alcohol consumption, longstanding limiting illness/disability, sleep time, screen time. 
Model 4: Model 3 plus hypertension, medication for high blood pressure, BMI, medication for high cholesterol, medication for diabetes, diabetes diagnosis. 
† For cancer outcomes Model 4 adjusted for all variables in Model 3 plus BMI only  
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Table A6: Prospective associations between travel mode and secondary outcomes for those regularly commuting and those not making regular commuting trips 
 
 
 
 
 
 
 
 
 
 
 
 Incident breast cancer  Breast cancer mortality Incident colon cancer Colon cancer mortality  
Regular commuters     
Commuting Events Person years Events Person years Events Person years Events Person years 
Relying exclusively on the 
car 696 825396 37 829719 283 1007112 73 1008479 
More active patterns of 
travel 409 461983 23 464452 152 567569 30 568229 
         
Model 1 N=183899 1.02 (0.90 to 1.15) N=184398 1.08 (0.63 to 1.86) N=220443 1.04 (0.85 to 1.28) N=220587 0.84 (0.54 to 1.31) 
Model 2  1.03 (0.90 to 1.17)  0.88 (0.49 to 1.57)  1.15 (0.91 to 1.45)  0.98 (0.61 to 1.58) 
Model 3  1.03 (0.91 to 1.18)  0.88 (0.49 to 1.58)  1.17 (0.92 to 1.48)  0.96 (0.59 to 1.57) 
Model 4  1.04 (0.91 to 1.19)  0.89 (0.50 to 1.59)  1.18 (0.93 to 1.50)  0.95 (0.58 to 1.56) 
Non-commuting travel Events Person years Events Person years Events Person years Events Person years 
Relying exclusively on the 
car 503 583187 28 586189 208 709478 55 710445 
More active patterns of 
travel 600 702487 32 706256 228 861870 50 862930 
         
Model 1 N=183661 0.97 (0.86 to 1.10) N=184158 0.95 (0.57 to 1.59) N=219987 0.93 (0.77 to 1.13) N=220131 0.79 (0.53 to 1.17) 
Model 2  0.98 (0.86 to 1.10)  0.82 (0.48 to 1.40)  0.95 (0.77 to 1.17)  0.78 (0.51 to 1.18) 
Model 3  1.01 (0.89 to 1.14)  0.84 (0.49 to 1.44)  0.97 (0.78 to 1.20)  0.79 (0.51 to 1.23) 
Model 4  1.01 (0.90 to 1.15)  0.84 (0.49 to 1.45)  0.98 (0.79 to 1.22)  0.79 (0.51 to 1.22) 
Those not making               regular 
commutes        
Non-commuting travel Events Person years Events Person years Events Person years Events Person years 
Relying exclusively on the 
car 405 395898 32 398494 298 621888 76 623492 
More active patterns of 
travel 734 744986 43 749889 626 1193579 147 1196739 
         
Model 1 N=165755 0.92 (0.82 to 1.05) N=166330 0.69 (0.43 to 1.10) N=259950 1.05 (0.91 to 1.21) N=260332 1.02 (0.77 to 1.35) 
Model 2  0.92 (0.81 to 1.04)  0.66 (0.41 to 1.06)  1.02 (0.87 to 1.19)  1.00 (0.72 to 1.38) 
Model 3  0.94 (0.82 to 1.06)  0.76 (0.47 to 1.24)  1.02 (0.86 to 1.20)  1.04 (0.74 to 1.47) 
Model 4  0.95 (0.83 to 1.08)  0.78 (0.48 to 1.27)  1.02 (0.86 to 1.21)  1.05 (0.75 to 1.48) 
